SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...

Valued at a market cap of $47.6 billion, Nasdaq, Inc. (NDAQ) is a global financial technology, trading, and market ...

On January 29, Nasdaq reported its fourth quarter and full year 2024 earnings. Nasdaq’s results reflected a year of strong financial and operational performance as well as strategic execution across ...

SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...

Q4 2024 Management View Barry Gosin, CEO, highlighted double-digit top-line growth across all major business lines, with management and servicing revenue up 21%, capital markets up 20%, and leasing up ...

Corporation's stock soared to a 52-week high of $15.12, reflecting a robust year for the investment firm. The company's impressive 33.29% one-year total return has been complemented by a substantial ...

EzFill Holdings (NASDAQ:EZFL) has announced the pricing of a public offering of 5 million shares of its common stock at $3.00 per share, for gross proceeds of approximately $15 million. Underwriters' ...

Rainbow Capital Holdings Limited (RCHL), a holding company incorporated in the British Virgin Islands, has filed an initial ...

FutureTech II Acquisition Corp. (NASDAQ:FTII), a micro-cap company with a market capitalization of approximately $60 million, has successfully regained compliance with Nasdaq's listing rules, the ...

Adena Friedman, chair and chief executive of Nasdaq, said the group’s Index business had an”exceptional” year in 2024, which ...

MENLO PARK, Calif. - Cyngn Inc. (NASDAQ:CYN), a developer of autonomous vehicle technology with a current market capitalization of $3.23 million, has announced a 1-for-150 reverse stock split of its ...